Predict your next investment

Novellus company logo
HEALTHCARE | Biotechnology
novellus.bio

See what CB Insights has to offer

Total Raised

$75.5M

Investors Count

11

Deal Terms

1

Novellus Funding, Novellus Valuation & Novellus Revenue

4 Fundings

Novellus's latest funding round was a Series C for $57M on September 21, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/21/2020

Series C

$57M

$0.00B

((9.99x))

FY 1234

6

4/30/2018

Series B - III

$99M

$0.00B

((9.99x))

FY 1234

10

6/21/2016

Series B - II

$99M

$0.00B

((9.99x))

FY 1234

10

12/24/2015

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

Date

9/21/2020

4/30/2018

6/21/2016

12/24/2015

Round

Series C

Series B - III

Series B - II

Series B

Amount

$57M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

6

10

10

10

Novellus Deal Terms

1 Deal Term

Novellus's deal structure is available for 1 funding round, including their Series B from December 24, 2015.

Round

Series B

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

Novellus Investors

11 Investors

Novellus has 11 investors. Pontifax invested in Novellus's Series C funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/24/2015

9/21/2020

2
Series B, Series C (2020)

Ran Nussbaum

Venture Capital

Israel

6/21/2016

9/21/2020

2
Series B - II, Series C (2020)

Venture Capital

New York

9/21/2020

9/21/2020

1
Series C

Asset/Investment Management

Massachusetts

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Switzerland

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Corporate Venture

Switzerland

First funding

12/24/2015

6/21/2016

9/21/2020

00/00/0000

00/00/0000

Last Funding

9/21/2020

9/21/2020

9/21/2020

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

2
Series B, Series C (2020)
2
Series B - II, Series C (2020)
1
Series C

Subscribe to see more

Subscribe to see more

Board Seats

Ran Nussbaum

Subscribe to see more

Subscribe to see more

Type

Venture Capital

Venture Capital

Asset/Investment Management

Venture Capital

Corporate Venture

Location

Israel

New York

Massachusetts

Switzerland

Switzerland

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.